Corgenix Medical, a developer of diagnostic test kits, has announced a collaboration with Battelle, a Columbus, Ohio-based independent R&D organization whose business focus includes national security.
Subscribe to our email newsletter
Under the collaboration, Corgenix will work with Battelle on biodefense related projects and programs.
Under the terms of the collaboration agreement, Corgenix will provide biodefense project support to Battelle in several areas, including prototype product development, production scale-up, technology transfer, manufacturing, quality control and regulatory compliance.
Douglass Simpson, president and CEO of Corgenix, said: “We are extremely pleased to collaborate with Battelle in their ongoing biodefense efforts. This is an important aspect of our nation’s defense, and Battelle is clearly in the premier position as a long-time provider of biodefense solutions to government and industry.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.